Free Trial
NASDAQ:ADGM

Adagio Medical Q3 2026 Earnings Date & Estimates

Adagio Medical logo
$0.09 0.00 (-0.23%)
As of 11:21 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Adagio Medical is estimated to report Q3 2026 earnings on Wednesday, November 11, 2026, before market opens. The conference call is scheduled for 9:30 AM ET.

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call
9:30 AM ET

What Analysts Expect from Adagio Medical in Q3 2026

Adagio Medical is expected to post earnings of -$0.2467 per share. In the same quarter a year earlier Adagio Medical reported -$0.66 per share. Adagio Medical last reported on August 11, 2026, posting -$0.30 per share and missing the -$0.27 consensus estimate.

Consensus Estimates

Consensus EPS
-$0.2467
Prior-Year EPS
-$0.66

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$0.30 (Missed by -$0.03)

Adagio Medical Q3 2026 Earnings FAQ

Adagio Medical (NASDAQ:ADGM) is estimated to report Q3 2026 earnings on Wednesday, November 11, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Adagio Medical's Q3 2026 earnings conference call is scheduled for Wednesday, November 11, 2026 at 9:30 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Adagio Medical to post earnings of -$0.2467 per share for Q3 2026.

Adagio Medical Earnings Headlines

ADGM - Adagio Medical Holdings, Inc.
The most dangerous moment in a financial crisis
Dr. Martin D. Weiss has publicly predicted six major American crashes since founding Weiss Ratings in 1971. Now, after 55 years of market analysis, he says conditions are forming for a financial crisis that could rival or exceed 2008.tc pixel
Adagio Medical Converts Notes to Equity Amid Review
See More Adagio Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Adagio Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Adagio Medical and other key companies, straight to your email.

About Adagio Medical

Adagio Medical (NASDAQ:ADGM), Inc. is a medical technology company focused on developing catheter-based treatments for cardiac arrhythmias, including atrial fibrillation. The company’s technology is designed to create continuous, transmural lesions in cardiac tissue to isolate abnormal electrical signals and help restore a normal heart rhythm.

Its lead platform is the Intelligent Continuous Lesion Ablation System (iCLAS), an ultra-low-temperature cryoablation system intended to treat atrial fibrillation and other heart rhythm disorders. The system is designed to deliver controlled, circumferential lesions through a catheter, with the goal of supporting more efficient and consistent cardiac ablation procedures.

Adagio Medical’s products are in the clinical-development and regulatory process, and the company has conducted clinical work in the United States and international markets. Its technology is intended for use by electrophysiologists and other cardiac specialists in hospital and specialized cardiovascular-care settings.

View Adagio Medical Profile